Best Grants for Museums in Puerto Rico

The NIOSH Centers for Agriculture, Forestry, and Fishing Safety and Health provide critical support to enhance worker safety and health in the vital AgFF sector. With a focus on high-quality interdisciplinary research, these centers aim to translate scientific findings into practical solutions, improve health outcomes, and engage with partners to promote best practices. By addressing health hazards and improving data coordination, these centers strive for a meaningful impact on the well-being of AgFF workers across the nation.

The NIOSH National Center of Excellence for the Prevention of Childhood Agricultural Injury (U54) aims to enhance the safety and well-being of youth in the agriculture sector. This initiative will conduct vital research, improve data collection, and implement effective interventions to mitigate risks faced by young workers. By collaborating with various stakeholders, the center seeks to translate scientific findings into practical solutions that promote healthier working environments for children in agriculture, forestry, and fishing industries.

This funding opportunity invites applications for pilot projects focused on understudied proteins linked to rare diseases. The goal is to generate preliminary data and tools related to these proteins, which belong to druggable families with known rare disease associations. By supporting innovative research, this initiative aims to facilitate the characterization of these proteins, ultimately contributing to advancements in understanding and treating rare diseases.

This Funding Opportunity Announcement (FOA) aims to advance the identification and evaluation of candidate biomarkers for neurological and neuromuscular disorders. By facilitating the clinical development of neurotherapeutics, the FOA encourages research that includes both animal studies and preliminary human evaluations. The ultimate goal is to produce biomarkers ready for rigorous analytical and clinical validation, enhancing the effectiveness of treatments in clinical practice.

The Limited Competition: Basic Instrumentation Grant (BIG) Program offers funding to NIH-supported researchers for purchasing specialized instruments or integrated systems, with minimum awards of $25,000 and maximum awards reaching $350,000. Eligibility is restricted to institutions that have not received significant S10 funding in recent years. This program aims to enhance research capabilities by providing access to essential technology, thereby fostering scientific innovation and collaboration within the NIH community.

The Shared Instrumentation Grant (SIG) Program supports NIH-funded investigators in acquiring high-cost, specialized instruments, with a minimum award of $50,000 and a maximum of $750,000. Eligible instruments include light microscopes, mass spectrometers, and DNA sequencers, among others. This program aims to enhance research capabilities by enabling the purchase or upgrade of essential equipment for scientific advancement.

The Dow Promise Grant empowers communities by addressing the unique barriers faced by Black youth and adults in the U.S. This program provides grants up to $10,000 for initiatives that promote social, economic, and environmental advancements. Since its inception in 2000, the Dow Promise Program has been committed to fostering equitable opportunities and positive social change, ultimately contributing to long-term community success and a brighter future for all.

The High-End Instrumentation (HEI) Grant Program, offered by the NIH, invites applications for purchasing or upgrading high-end, specialized instruments, with a minimum award of $750,001 and a maximum of $2,000,000. This program supports NIH investigators aiming to enhance their research capabilities through advanced technologies such as mass spectrometers and electron microscopes. Applications must be submitted by 5:00 pm local time of the applicant organization.

The NALAC Fund for the Arts offers organization grants focused on supporting Latinx artists and arts organizations in the U.S. and Puerto Rico. This funding initiative has invested over $6 million in the arts community, nurturing creativity and social change. Eligible applicants include organizations with a mission centered on Latinx arts. The program aims to enhance artistic excellence and community engagement, making it a vital resource for cultural production and social justice efforts.

The NIH is seeking innovative computational approaches to enhance the curation of biomedical research assets at scale. This initiative aims to accelerate access to secure datasets and computational models, facilitating transformative discoveries in biomedical science. Key deadlines for applications range from January 2025 to January 2027, covering standard, renewal, and AIDS-related grants. Applicants are encouraged to submit Letters of Intent 30 days prior to application deadlines to ensure a streamlined review process.

Gilead Medical Education Grants fund innovative, data-driven programs that enhance healthcare infrastructure and support vulnerable communities globally. Focused on core therapeutic areas like HIV, liver diseases, and oncology, these grants aim to deliver impactful continuing medical education for healthcare providers. Eligible applicants include for-profit medical education companies and nonprofit organizations. Gilead prioritizes programs that demonstrate a strong capacity to achieve specific educational outcomes, ensuring that support reaches those who need it most.

The Rural Business Development Grants in Puerto Rico aim to enhance small rural businesses through technical assistance and training. With no maximum grant amount, priority is given to smaller requests, and funds can be utilized for various projects including training, land development, and pollution control. Eligible applicants include rural public entities and nonprofits that serve communities outside urban centers. This initiative fosters economic growth and innovation in underserved areas, ensuring sustainable development for local businesses.

The Russell Sage Foundation offers Dissertation Research Grants to support innovative research addressing key social science questions. Focus areas include behavioral science, immigration, and economic inequality, particularly benefiting underrepresented doctoral students. Grants of up to $15,000 are available for projects that demonstrate rigorous methods and relevance to U.S. social conditions. The foundation prioritizes diverse applicants and those lacking funding resources to ensure impactful research outcomes.

The Pilot Projects to Enhance the Human Virome Program (R03) aims to support small-scale research projects that enhance the understanding of the human virome. This initiative encourages innovative approaches to study virome interactions and improve tools developed under the Human Virome Program. By leveraging human and animal specimens, projects should foster collaboration and expand existing research efforts, ultimately contributing to a deeper understanding of the virome's role in health and disease.

The NIH R25 program enhances clinician-scientists' involvement in research by supporting educational activities aimed at recruiting individuals from diverse backgrounds into biomedical, behavioral, and clinical sciences. This initiative promotes the development of research experiences and mentoring networks to foster a robust research workforce. Applications are due by 5:00 PM local time of the applicant's organization, providing an opportunity for engaging with the NIH's mission.

The Seeding Critical Advances for Leading Energy Technologies (Scaleup) Ready initiative by ARPA-E invites applications for funding to advance transformative energy technologies. This program supports innovative projects that demonstrate potential for significant market disruption and emphasizes rigorous project management and technology risk mitigation. Eligible organizations must have inventions conceived during an ARPA-E award, reported in the iEdison system, and hold relevant U.S. patent applications. For further details, visit ARPA-E's website.

The NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) grant aims to facilitate high-quality conferences that align with public health and scientific missions. Key deadlines include December 12, 2024, April 12, 2025, and August 12, 2025, among others, specifically for AIDS-related applications. This funding opportunity is provided by the US Department of Health & Human Services: National Institutes of Health (NIH).

The Cancer Center Support Grants (CCSGs) aim to bolster NCI-Designated Cancer Centers by funding comprehensive, clinical, and basic cancer research. These grants facilitate the integration of diverse research capabilities, promoting innovative approaches to cancer prevention, diagnosis, and therapy. CCSGs encourage collaboration among researchers and the development of Shared Resources, ultimately enhancing the understanding of cancer and its treatment. This initiative supports the continuous discovery and dissemination of crucial research findings for community benefit.

This funding opportunity aims to enhance understanding of chemical-induced skin injuries, particularly those recognized as public health threats. The initiative encourages research focused on identifying commonalities in these injuries and exploring shared signaling pathways. By investigating therapeutic targets, this program seeks to develop effective medical countermeasures. Multiple application deadlines are set from 2025 to 2027, supporting diverse research proposals in this crucial area.

The National Cancer Institute (NCI) invites research applications focused on early-onset cancers (ages 18-49), aiming to uncover their etiology and biological mechanisms. This funding opportunity supports studies that explore modifiable risk factors, biological responses, and improved identification of at-risk individuals. The initiative seeks to address the concerning rise in these cancers among young adults, facilitating essential prevention and control strategies. Applicants can choose between exploratory or research project formats, with project durations ranging from 2 to 5 years.

The NIDCR is inviting applications for the continuation or revision of ongoing clinical trials through the UH3 Clinical Trial Required grant. This opportunity supports extensions for completing trials or longer follow-up periods, as well as revisions that are well justified. Key deadlines for submissions are set from March 2025 to January 2028, with optional Letters of Intent encouraged thirty days prior to application due dates. Ensure compliance with the outlined requirements to enhance your chances of funding.

The Women's Initiative for Screening and Health (WISH) aims to enhance women's health by improving access to preventive services. It focuses on updating HRSA-supported guidelines, increasing awareness of these guidelines, and promoting their adoption in clinical practice. By collaborating with healthcare providers, academic institutions, and patient organizations, WISH strives to implement a comprehensive strategy that benefits women's health across their lifespan.

The Specialty Crop Multi-State Grant Program 2026, managed by the USDA Agricultural Marketing Service, invites applications for projects that enhance the competitiveness of specialty crops through collaborative multi-state efforts. This initiative aims to address pressing regional and national issues such as food safety and plant diseases, while promoting marketing strategies. Eligible projects should demonstrate measurable benefits across multiple U.S. states or territories, ensuring a broader impact on the specialty crop industry.

The NIH is inviting applications for interventions aimed at enhancing cancer screening and preventive services in underserved populations. This initiative focuses on addressing barriers to healthcare access and promoting timely follow-up on abnormal findings. Collaborations with community partners are encouraged to foster effective outreach. The program particularly seeks to engage patients, clinicians, and healthcare settings in improving health equity and outcomes in cancer prevention.

The National Cancer Institute (NCI) seeks to enhance the validation of biomarkers and assays for cancer detection and treatment through its UH3 funding mechanism. This initiative supports multi-disciplinary collaborations to validate existing assays over three years using clinical trial specimens. Emphasis is placed on harmonizing laboratory tests and validating pharmacodynamic markers. Projects should not focus on early-stage technology development but aim for integration into clinical studies as investigational assays.

The Changemakers in Family Planning Grant Program aims to address institutionalized racism in the field of family planning by providing essential support to scholars of color. Recognizing that diversity and equity are crucial for advancing research in abortion and contraception, this initiative seeks to foster an inclusive community that empowers underrepresented voices in science. The Society of Family Planning is dedicated to creating a just environment where all scholars can contribute to meaningful advancements in family planning research.

The National Cancer Institute (NCI) invites applications for the validation of molecular, cellular, and imaging markers for cancer detection and treatment. This funding opportunity supports both analytical and clinical validation phases, emphasizing multi-disciplinary collaboration. The UH2 phase focuses on analytical validation, while the UH3 phase extends to clinical validation using well-annotated biospecimens. Proposals should justify the relevance of assays for clinical use and may include harmonization efforts across laboratories.